COMMUNITY HEALTH SYSTEMS INC·4

Mar 3, 4:44 PM ET

Williams Hubert James 4

4 · COMMUNITY HEALTH SYSTEMS INC · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Community Health Systems (CYH) Director Hubert Williams Exercises Derivatives, Receives Award

What Happened

  • Hubert James Williams, a director of Community Health Systems, reported derivative exercises/conversions and a grant on March 1, 2026. He exercised/converted three derivative lots totaling 50,595 shares (9,756; 20,906; 19,933), each reported at $0.00, and those same amounts were also reported as disposed (derivative). In addition, he was granted 52,023 restricted stock units (RSUs) reported at $0.00.
  • Footnote F1 indicates the derivatives convert to common stock on a one-for-one basis. The grant is in the form of RSUs (see F2/F3 for vesting/settlement terms). No cash changed hands on the reported entries (all prices listed as $0.00).

Key Details

  • Transaction date(s): March 1, 2026; Filing date: March 3, 2026 (Form 4 accession 0001193125-26-088486).
  • Prices: all reported at $0.00 (derivative exercises/conversions and RSU grant).
  • Shares involved: 50,595 shares exercised/converted (and simultaneously reported disposed as derivative) + 52,023 RSUs granted.
  • Shares owned after transaction: not specified in the provided filing summary.
  • Footnotes of note:
    • F1: conversion is one-to-one into common stock.
    • F2: RSUs vest in 1/3 increments on the first, second and third anniversaries of the grant and settle one-for-one into common stock.
    • F3: some RSUs vested in thirds previously and, per the reporting person’s deferral elections, will settle in shares upon cessation as a director or on previously specified dates.
  • Timeliness: filing appears to have been submitted within the standard short reporting window (transaction Mar 1, filed Mar 3, 2026).

Context

  • The filing shows derivative conversions and an RSU grant rather than an open-market purchase or sale. Reporting both an “acquired” and a “disposed” entry for the same derivative amounts (at $0) commonly reflects a conversion/settlement process rather than a cash purchase; F1 clarifies the 1:1 conversion to common stock.
  • RSU grants are compensation/retention awards; vesting and settlement rules (F2/F3) determine when they convert to shares. These events are generally routine for insiders and do not, by themselves, signal a buy or sell opinion.

Insider Transaction Report

Form 4
Period: 2026-03-01
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-01+9,756171,024 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-01+20,906191,930 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-01+19,933211,863 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2]
    2026-03-019,7560 total
    Exercise: $0.00Common Stock (9,756 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F2]
    2026-03-0120,90620,906 total
    Exercise: $0.00Common Stock (20,906 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F2]
    2026-03-0119,93339,868 total
    Exercise: $0.00Common Stock (19,933 underlying)
  • Award

    Restricted Stock Units

    [F2]
    2026-03-01+52,02352,023 total
    Exercise: $0.00Common Stock (52,023 underlying)
Holdings
  • Restricted Stock Units

    [F3]
    Exercise: $0.00Common Stock (53,779 underlying)
    53,779
Footnotes (3)
  • [F1]The security converts to common stock on a one-to-one basis.
  • [F2]These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.
  • [F3]These restricted stock units vested in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.
Signature
Christopher G. Cobb, Attorney in Fact for Hubert James Williams|2026-03-03

Documents

2 files